摘要:目的:觀察美托洛爾對(duì)高血壓并慢性心衰(CHF)患者的心功能影響及臨床療效。方法:擇高血壓并高心病或冠心病60例,心功能Ⅱ～Ⅳ級(jí)的患者,隨機(jī)分為兩組,常規(guī)組(30例),給與控制血壓、利尿、轉(zhuǎn)換酶抑制劑(ACEI)、洋地黃治療。美托洛爾組(30例),在常規(guī)治療基礎(chǔ)上加用美托洛爾。結(jié)果：美托洛爾組臨床顯效率(667%),總有效率(93.4%),較常規(guī)組顯著提高(P lt;0.05)。美托洛爾組與常規(guī)組治療前后,心率、血壓、左室舒張末期直徑、左室收縮末期直徑、左室射血分?jǐn)?shù)、心輸出量、E/A、等容舒張期時(shí)間均有顯著改善(美托洛爾組P lt;0.01,常規(guī)組P lt;0.05),且美托洛爾組上述指標(biāo)改善更明顯(P lt;0.01或P lt;0.05)。結(jié)論:美托洛爾顯著改善高血壓并慢性心力衰竭患者的心功能,是一種安全有效的治療方法。
Abstract: Objective: To observe US to hold Luo river to hypertension and the chronic heart failure (CHF) patient’s heart function influence and the clinical curative effect. Methods: Selects hypertension and the high worry or the coronary disease 60 examples, the heart functionⅡ~ⅣThe level patient, divides into two groups stochastically, the conventional group (30 examples), gives the control blood pressure, the diuresis, the transformation enzyme inhibitor (ACEI), the digitalis treatment. US holds Luo river Zu (30 examples), adds in the conventional treatment foundation with US holds Luo river. Results: US holds the Luo river group clinical obviously efficiency (66.7%), the total effectiveness (93.4%), compares the conventional group remarkable enhancement (P lt;0.05). Around US holds Luo river Zu and the conventional group treats, the heart rate, the blood pressure, the left room diastole last stage diameter, the left room contraction last stage diameter, the left room shoot the menstruation number, the cardiac output, E/A, the constant volume relaxing period time to have the remarkable improvement (US to hold Luo river ZuP lt;0.01, conventional group (P lt;0.05), and US holds the Luo river group above target improvement to be more obvious (P lt;001 or P lt;0.05). Conclusion: US holds Luo river obviously to improve hypertension and the chronic heart
引用本文： 闞光澍. 美托洛爾治療高血壓并慢性心力衰竭療效觀察. 華西醫(yī)學(xué), 2009, 24(11): 2858-2859. doi: 復(fù)制